[Corrective and protective effects of adenosine-5-triphosphoric acid against neurological syndromes induced by neuroleptics].
D000227:Adenine Nucleotides / Q000628:therapy*; D000241:Adenosine; D000255:Adenosine Triphosphate; D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D009420:Nervous System / Q000494:pharmacology*; D011122:Polyphosphates; D013577:Syndrome; D014149:Tranquilizing Agents / Q000633:toxicity*
D000227:Adenine Nucleotides; D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D011122:Polyphosphates; D014149:Tranquilizing Agents; D000255:Adenosine Triphosphate; D000241:Adenosine; C005692:triphosphoric acid
ADENOSINE PHOSPHATES/therapy; NERVOUS SYSTEM/pharmacology; TRANQUILIZING AGENTS/toxicology